LAG3 and diffuse large B-cell lymphoma: In the context of hematological cancers, LAG-3 expression has been correlated with the prognosis of CLL, acute myeloid leukemia (AML), follicular lymphoma (FL), and diffuse large B-cell lymphoma (DLBCL) patients [49, 58, 95–97].